Left Menu
Development News Edition

Delhi-based Dr Dangs selected as central lab for Covaxin human clinical trials

"We are extremely privileged to announce that Dr. Dangs Lab, New Delhi has been provided the opportunity to serve the nation by being selected as the central lab for the Human Clinical trials of Covaxin; India's indigenous COVID-19 vaccine being developed and manufactured by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV)," it said in a statement. This is a "randomised, double blind, placebo controlled multi-centric clinical trial in India", it added.

PTI | New Delhi | Updated: 23-07-2020 14:46 IST | Created: 23-07-2020 14:46 IST
Delhi-based Dr Dangs selected as central lab for Covaxin human clinical trials

A Delhi-based private laboratory has claimed that it has been selected as the central lab for human clinical trials of Covaxin, India's indigenous COVID-19 vaccine candidate. The vaccine is being developed and manufactured by Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology.

Dr. Dangs Lab said on Wednesday that it has partnered with Bharat Biotech for conducting the trials. "We are extremely privileged to announce that Dr. Dangs Lab, New Delhi has been provided the opportunity to serve the nation by being selected as the central lab for the Human Clinical trials of Covaxin; India's indigenous COVID-19 vaccine being developed and manufactured by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV)," it said in a statement.

This is a "randomised, double blind, placebo controlled multi-centric clinical trial in India", it added. "Dr. Dangs Lab is currently processing all samples for screening and safety for the various phases of this clinical trial, whereas all the efficacy studies will be performed in NIV (Pune)," the statement said.

The lab has already started receiving samples from 50 to 100 subjects per day from various trial sites for safety testing and will be increasing operations as per assigned timelines to cover 12 sites across the length and breadth of the country over this month, it added. "Stringent quality norms driven by good clinical laboratory practice (GCLP) guidelines are being followed as mandated by regulatory authorities. The lab has renowned experts in each field who are working tirelessly and collectively to provide quality and timely results to fulfil the imminent need of an effective and safe COVID19 vaccine," the statement said.


TRENDING

OPINION / BLOG / INTERVIEW

Uganda COVID-19 response: Was off to a good start but reopening dwindled prospects

Uganda has shown success in using health information to enhance efficiency of disease surveillance, reporting and monitoring. The success, however, has critical challenges confronting it as the country resumes normal activities....

New farm bills in India: Focusing on farms or farmers?

... ...

Kenya’s COVID-19 response: Chaos amid lack of information

Confusing numbers and scanty information on how effective curfews and lockdowns have been in breaking transmission have amplified coordination and planning challenges in Kenyas response to COVID-19. Without accurate data, it is impossible t...

Farkhad Akhmedov: Calculating the price of impunity from the law

In insistences such as the battle over the Luna, Akhmedov has resorted to extreme legal machinations to subvert the High Courts decision and keep his assets from being seized. ...

Videos

Latest News

Cong to 'gherao' Uttarakhand CM's residence over HC order on registration of FIR

A day after Uttarakhand High Court directed CBI to register an FIR against the Chief Minister Trivendra Singh Rawat, the state in-charge of Congress Devendra Yadav called the allegation against Chief Minister serious and said his party gher...

Entertainment News Roundup: Comedian Jon Stewart to return to TV on Apple's streaming service; AMC to reopen eight theaters in California

Following is a summary of current entertainment news briefs.Comedian Jon Stewart to return to TV on Apples streaming serviceFormer Daily Show host Jon Stewart will host and produce a new current affairs series for Apple Incs streaming telev...

Turkey condemns French caricature featuring Erdogan

Top Turkish officials condemned a caricature scorning President Tayyip Erdogan in the French satirical weekly Charlie Hebdo on Wednesday, calling it a disgusting effort to spread its cultural racism and hatred. Turkish anger at the caricatu...

Ronaldo to miss Barcelona clash after testing positive for coronavirus again

Cristiano Ronaldo is all set to miss Juventus Champions League clash against Barcelona as the player has tested positive for coronavirus again. In order to play Juventus upcoming Champions League match, the Portuguese was needed to test neg...

Give Feedback